pirenzepine has been researched along with Childhood Schizophrenia in 4 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The treating clinician was free to vary or discontinue dosing and use additional medications." | 2.71 | A 1-year open-label trial of olanzapine in school-age children with schizophrenia. ( Adler, LE; Farley, GK; Novins, D; Ross, RG, 2003) |
| " Blood samples, collected during dose titration and at a steady state provided pharmacokinetic data." | 2.69 | Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia. ( Bergstrom, RF; Calis, KA; DeVane, CL; Grothe, DR; Jacobsen, L; Kumra, S; Kurtz, DL; Rapoport, JL, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ross, RG | 1 |
| Novins, D | 1 |
| Farley, GK | 1 |
| Adler, LE | 1 |
| Mozes, T | 1 |
| Greenberg, Y | 1 |
| Spivak, B | 1 |
| Tyano, S | 1 |
| Weizman, A | 1 |
| Mester, R | 1 |
| Grothe, DR | 1 |
| Calis, KA | 1 |
| Jacobsen, L | 1 |
| Kumra, S | 1 |
| DeVane, CL | 1 |
| Rapoport, JL | 1 |
| Bergstrom, RF | 1 |
| Kurtz, DL | 1 |
| Sholevar, EH | 1 |
| Baron, DA | 1 |
| Hardie, TL | 1 |
4 trials available for pirenzepine and Childhood Schizophrenia
| Article | Year |
|---|---|
A 1-year open-label trial of olanzapine in school-age children with schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Drug Resistance; Female; Humans; Male; Ola | 2003 |
Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label study.
Topics: Adolescent; Age of Onset; Antipsychotic Agents; Benzodiazepines; Child; Drug Resistance; Female; Fol | 2003 |
Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Child; Dose-Response Relationship, Drug; D | 2000 |
Treatment of childhood-onset schizophrenia with olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Child; Female; Humans; Male; Olanzapine; Pirenzepine; Psychia | 2000 |